The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
BBC 10pm news item soon.
Daily mail item includes;
“Holly participated in a ground-breaking Cancer Research UK-funded trial investigating whether a new drug may allow doctors to lower the dose of toxic chemotherapy.”
Maybe email Avacta and point out what appears to be human error. They happen.
Ignore the disparaging comments from the bully boys and please wind them as up as much as possible. It helps to pass time until we make our millions and cancer takes a back seat.
We're pleased to welcome you to our new, state-of-the-art laboratories at @scale_space! The facilities will drive the progression of our novel #cancertherapeutics through the clinic, in our mission to deliver safer, better tolerated treatments to patients: bit.ly/3CbIphW